The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study
The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study
Active, not recruiting · NCT02520713 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study | Pediatric Solid Tumor | Active, not recruiting | Not stated | 2026-09-21 | NCT02520713 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dana-Farber Cancer Institute | 324 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Boston Children's Hospital | Boston | United States | 20 |
| Children's Hospital Colorado | Aurora | United States | 312 |
| Children's Hospital of Philadelphia | Philadelphia | United States | 434 |
| Children's National Medical Center | Washington D.C. | United States | 177 |
| Columbia University Medical center | New York | United States | 224 |
| Dana-Farber Cancer Institute | Boston | United States | 626 |
| Nationwide Children's Hospital | Columbus | United States | 309 |
| Seattle Children's Hospital | Seattle | United States | 281 |
| University of California San Francisco | San Francisco | United States | 80 |
| University of Chicago Comer Children's Hospital | Chicago | United States | 4 |
| University of Texas Southwestern Medical Center at Dallas | Dallas | United States | 10 |
| University of Utah Childrens Medical Center | Salt Lake City | United States | 2 |